A detailed history of Fmr LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Fmr LLC holds 14,578,812 shares of EW stock, worth $1.26 Billion. This represents 0.06% of its overall portfolio holdings.

Number of Shares
14,578,812
Previous 2,527,936 476.71%
Holding current value
$1.26 Billion
Previous $198 Million 473.47%
% of portfolio
0.06%
Previous 0.01%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025

BUY
$73.75 - $81.83 $889 Million - $986 Million
12,050,876 Added 476.71%
14,578,812 $1.13 Billion
Q2 2025

Aug 14, 2025

BUY
$67.07 - $78.22 $2.83 Million - $3.3 Million
42,179 Added 1.7%
2,527,936 $198 Million
Q1 2025

May 12, 2025

BUY
$67.95 - $76.19 $3.87 Million - $4.34 Million
57,014 Added 2.35%
2,485,757 $180 Million
Q4 2024

Feb 13, 2025

BUY
$64.54 - $75.92 $37.4 Million - $44 Million
579,541 Added 31.34%
2,428,743 $180 Million
Q3 2024

Nov 13, 2024

SELL
$59.7 - $93.78 $345 Million - $541 Million
-5,773,245 Reduced 75.74%
1,849,202 $122 Million
Q2 2024

Aug 13, 2024

SELL
$84.3 - $94.31 $52 Million - $58.2 Million
-617,049 Reduced 7.49%
7,622,447 $704 Million
Q1 2024

May 13, 2024

BUY
$72.54 - $95.56 $53.5 Million - $70.5 Million
737,442 Added 9.83%
8,239,496 $787 Million
Q4 2023

Feb 13, 2024

BUY
$61.71 - $77.76 $271 Million - $341 Million
4,390,669 Added 141.12%
7,502,054 $572 Million
Q3 2023

Nov 13, 2023

BUY
$69.28 - $93.38 $81.7 Million - $110 Million
1,179,637 Added 61.07%
3,111,385 $216 Million
Q2 2023

Aug 11, 2023

BUY
$81.41 - $94.33 $7.12 Million - $8.25 Million
87,431 Added 4.74%
1,931,748 $182 Million
Q1 2023

May 11, 2023

SELL
$74.26 - $84.51 $9.89 Million - $11.3 Million
-133,167 Reduced 6.73%
1,844,317 $153 Million
Q4 2022

Feb 13, 2023

SELL
$68.3 - $87.44 $317 Million - $406 Million
-4,643,634 Reduced 70.13%
1,977,484 $148 Million
Q3 2022

Nov 10, 2022

SELL
$82.37 - $107.29 $185 Million - $240 Million
-2,240,274 Reduced 25.28%
6,621,118 $547 Million
Q2 2022

Aug 12, 2022

BUY
$86.5 - $128.27 $108 Million - $160 Million
1,244,420 Added 16.34%
8,861,392 $843 Million
Q1 2022

May 13, 2022

SELL
$101.96 - $128.34 $75.8 Million - $95.4 Million
-743,404 Reduced 8.89%
7,616,972 $897 Million
Q4 2021

Feb 14, 2022

SELL
$106.37 - $130.68 $37.9 Million - $46.6 Million
-356,322 Reduced 4.09%
8,360,376 $1.08 Billion
Q3 2021

Nov 15, 2021

BUY
$102.91 - $122.75 $121 Million - $145 Million
1,180,500 Added 15.66%
8,716,698 $987 Million
Q2 2021

Aug 13, 2021

BUY
$83.84 - $104.76 $632 Million - $789 Million
7,536,198 New
7,536,198 $781 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $53.4B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.